Cytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.74 million.

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.